0001567619-18-008189.txt : 20181218 0001567619-18-008189.hdr.sgml : 20181218 20181218134732 ACCESSION NUMBER: 0001567619-18-008189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181217 FILED AS OF DATE: 20181218 DATE AS OF CHANGE: 20181218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murley Robert S CENTRAL INDEX KEY: 0001523923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35811 FILM NUMBER: 181240060 MAIL ADDRESS: STREET 1: 4025 S. RIVERPOINT PARKWAY STREET 2: M/S CF-K815 CITY: PHOENIX STATE: AZ ZIP: 85040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Insurance Innovations, Inc. CENTRAL INDEX KEY: 0001561387 STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411] IRS NUMBER: 461282634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 BUSINESS PHONE: 813-397-1187 MAIL ADDRESS: STREET 1: 15438 N. FLORIDA AVENUE STREET 2: SUITE 201 CITY: TAMPA STATE: FL ZIP: 33613 4 1 doc1.xml FORM 4 X0306 4 2018-12-17 0 0001561387 Health Insurance Innovations, Inc. HIIQ 0001523923 Murley Robert S C/O HEALTH INSURANCE INNOVATIONS, INC. 15438 NORTH FLORIDA AVENUE, SUITE 201 TAMPA FL 33613 1 0 0 0 Class A Common Stock 2018-12-17 4 P 0 5000 30.85 A 5000 I By Robert Murley Revocable Trust Class A Common Stock 2018-12-17 4 P 0 1500 30.84 A 1500 I By Murley Enterprises The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.67 to $31.10, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $30.74 to $31.05, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. /s/ Michael Hershberger, Attorney-in-Fact for Robert S. Murley 2018-12-18